Navigation Links
Course of West Nile Infection Charted
Date:3/18/2009

Scientists found levels of certain cytokines spiked during disease stage

WEDNESDAY, March 18 (HealthDay News) -- Scientists in South Africa recently had the rare opportunity to follow the West Nile virus from initial infection through symptoms and recovery in a 29-year-old lab worker who had accidentally jabbed herself with an infected needle.

In particular, the researchers followed the trajectory of cytokines, a type of signaling molecule in the body, as the patient progressed through the illness.

"There are currently no specific treatments for neurological West Nile virus infections," said Marietjie Venter, head of the respiratory and emerging neurological virus program in the department of medical virology at the University of Pretoria in South Africa and co-author of a letter in the March 19 issue of the New England Journal of Medicine. "Cytokines may serve as potential targets for treatment," Venter said.

Another expert said the importance of the report lies more in the basic science knowledge it provides for West Nile, which has been endemic in North America since its first appearance in 1999.

"They were able to link the course of the infection to basic science," said Dr. Pascal James Imperato, dean and distinguished service professor at State University of New York (SUNY) Downstate Medical Center in New York City. "The interest here lies in the range of cytokines which were produced and the levels at which they were produced at different points of time."

People infected with West Nile, which is typically passed from birds to mosquitoes to humans, can experience a range of symptoms, from mild, flu-like aches and pains to life-threatening encephalitis (inflammation of the brain).

These researchers, in effect, had the opportunity to carry out a serendipitous controlled trial when the 29-year-old woman, who was HIV-negative, pricked herself with the needle.

The woman's symptoms began one week after the needle mishap and included, at first, backache and stiffness in the neck. This was soon followed by a mild fever and symptoms of meningoencephalitis (inflammation of the brain and surrounding membrane) such as severe headache, sensitivity to light and joint pain.

The symptoms subsided in about three weeks, and the woman had completely recovered by day 26 post-infection.

Blood levels of 16 cytokines were measured on the day of infection and eight subsequent days, including the day of full recovery, and compared to a blood sample taken from the patient five years after her illness.

They found that levels of the cytokines interferon-alpha and interleukin-13, both of which have effects on the immune system, were elevated.

The authors speculated that increased levels of interferon-a might help treat neurological infection from West Nile, because interferon-a has a dampening effect on the inflammatory responses of the body.

According to Venter, two patients with West Nile Virus-related encephalitis had shown improvement when treated with interferon alpha.

"Our study confirms that this cytokine increases to high levels when symptoms became apparent in our patient and supports the use of interferon alpha 2 beta as a treatment," she said. "Other cytokines that have been highlighted in the course of this neurological case that warrant further research for their role in controlling West Nile Virus infection include interferon inducible protein 10 (IP10) and interleukin 13."

"The case study also highlights that this strain of the virus, West Nile virus lineage 2, which is endemic to Southern Africa, may cause severe disease and should be considered as a cause of neurological disease to patients living here and travelers to this area," Venter added. "This contradicts the general belief that West Nile Virus lineage 2 only causes mild disease but rather suggests that it may be an underappreciated cause of neurological infection in Southern Africa."

Also, the patient had received the Yellow Fever vaccine shortly before the accident, suggesting that the vaccine is not protective against West Nile, as had been suspected.

More information

The U.S. Centers for Disease Control and Prevention has more on West Nile virus.



SOURCES: Marietjie Venter, Ph.D., head, respiratory and emerging neurological virus program, department of medical virology, University of Pretoria, South Africa; Pascal James Imperato, M.D., dean, and distinguished service professor, graduate program in public health, State University of New York (SUNY) Downstate Medical Center, New York City; March 19, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New research shows how chronic stress worsens neurodegenerative disease course
2. ABQAURP Announces Certificate Course in Medical Error Prevention
3. Speedier skis on course for World Cup glory
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. ABIH Approves Certification Credit for SSPC Training Courses
6. Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication
7. Pursuing parenthood: Discourses of persistence
8. Silverchair Learning Systems Updates and Develops New Courses
9. U.S. Career Institute Launches 1st Ever DETC Accredited Medical Assistant Course
10. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
11. DRAXIS Announces Application for Normal Course Issuer Bid
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Course of West Nile Infection Charted
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: